Amersham Anti-CHO HCP Antibody, Supernatant, 100 µg (29496739) is an antibody reagent for host cell protein workflows involving CHO supernatant samples. It is part of the Amersham HCPQuant CHO product family and is intended to support HCP quantification and characterisation during process-derived sample analysis.
Key Features
- CHO supernatant HCP antibody format, specified by Cytiva for Amersham anti-CHO HCP Antibody use with supernatant-derived samples
- 100 µg tube configuration, matching the smaller antibody pack size listed for this product family
- Protein A affinity purified antibody, purified from rabbit serum according to Cytiva instructions for use
- Supports HCP characterisation workflows, including use in process-derived CHO supernatant sample analysis
- Suitable for 2D Western blotting workflows, supporting orthogonal host cell protein coverage assessment
- Part of the Amersham HCPQuant CHO family, aligned with Cytiva products for CHO HCP impurity detection and quantification
Benefits
- Helps laboratories assess CHO host cell proteins in supernatant-derived process samples.
- Supports HCP management strategies when moving from generic methods toward more process-specific understanding.
- Provides a defined 100 µg antibody format for teams that do not require the larger 1 mg pack size.
- Can be used alongside complementary Amersham HCPQuant CHO products for impurity detection and characterisation workflows.
Why Choose the Amersham Anti-CHO HCP Antibody, Supernatant, 100 µg (29496739)?
Amersham Anti-CHO HCP Antibody, Supernatant, 100 µg (29496739) is suitable where a dedicated antibody reagent is required for CHO supernatant host cell protein workflows. John Morris Group can supply this Amersham antibody format for Australian laboratories and assist with matching it to the required HCP analysis workflow.
